BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15883708)

  • 1. Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features.
    Gläsker S
    Fam Cancer; 2005; 4(1):37-42. PubMed ID: 15883708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.
    Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M
    J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.
    Conway JE; Chou D; Clatterbuck RE; Brem H; Long DM; Rigamonti D
    Neurosurgery; 2001 Jan; 48(1):55-62; discussion 62-3. PubMed ID: 11152361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease.
    Weil RJ; Lonser RR; DeVroom HL; Wanebo JE; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):95-105. PubMed ID: 12546357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
    Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic manifestations of von Hippel-Lindau disease.
    Butman JA; Linehan WM; Lonser RR
    JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: benefits, risks and outcome.
    Pavesi G; Feletti A; Berlucchi S; Opocher G; Martella M; Murgia A; Scienza R
    J Neurosurg Sci; 2008 Jun; 52(2):29-36. PubMed ID: 18500215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
    Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L
    Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
    Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
    Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment.
    Klingler JH; Gläsker S; Bausch B; Urbach H; Krauss T; Jilg CA; Steiert C; Puzik A; Neumann-Haefelin E; Kotsis F; Agostini H; Neumann HPH; Beck J
    Childs Nerv Syst; 2020 Oct; 36(10):2537-2552. PubMed ID: 32507909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Hippel-Lindau development in children and adolescents.
    Launbjerg K; Bache I; Galanakis M; Bisgaard ML; Binderup MLM
    Am J Med Genet A; 2017 Sep; 173(9):2381-2394. PubMed ID: 28650583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
    Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
    Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature.
    Whitman A; Damodharan S; Bhatia A; Puccetti D; Iskandar B
    Childs Nerv Syst; 2023 May; 39(5):1361-1363. PubMed ID: 36708374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
    Richard S; Martin S; David P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemangioblastomas and Other Vascular Origating Tumors of Brain or Spinal Cord.
    Vetrano IG; Gioppo A; Faragò G; Pinzi V; Pollo B; Broggi M; Schiariti M; Ferroli P; Acerbi F
    Adv Exp Med Biol; 2023; 1405():377-403. PubMed ID: 37452946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric central nervous system hemangioblastomas: different from adult forms? A retrospective series of 25 cases.
    Cheng J; Liu W; Hui X; Zhang S; Ju Y
    Acta Neurochir (Wien); 2017 Sep; 159(9):1603-1611. PubMed ID: 28752202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease.
    Jagannathan J; Lonser RR; Smith R; DeVroom HL; Oldfield EH
    J Neurosurg; 2008 Feb; 108(2):210-22. PubMed ID: 18240914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease.
    Lonser RR; Weil RJ; Wanebo JE; DeVroom HL; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):106-16. PubMed ID: 12546358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE.
    Krzystolik K; Stopa M; Kuprjanowicz L; Drobek-Slowik M; Cybulski C; Jakubowska A; Gronwald J; Lubiński J; Lubiński W
    Retina; 2016 Feb; 36(2):325-34. PubMed ID: 26308528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental effects of von Hippel-Lindau gene deficiency.
    Vortmeyer AO; Yuan Q; Lee YS; Zhuang Z; Oldfield EH
    Ann Neurol; 2004 May; 55(5):721-8. PubMed ID: 15122713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.